We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$813M
AUM Growth
+$43.5M
Cap. Flow
-$1.74M
Cap. Flow %
-0.21%
Top 10 Hldgs %
20.71%
Holding
251
New
10
Increased
63
Reduced
107
Closed
7

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$2.9M
2
AL
Air Lease Corp
AL
+$2.05M
3
IQV icon
IQVIA
IQV
+$1.92M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.89M
5
GE icon
GE Aerospace
GE
+$1.74M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.64M
2
MIDD icon
Middleby
MIDD
+$2.44M
3
GILD icon
Gilead Sciences
GILD
+$1.58M
4
ROK icon
Rockwell Automation
ROK
+$1.34M
5
AAPL icon
Apple
AAPL
+$1.04M

Sector Composition

Rank Sector Weight
1 Healthcare 17.01%
2 Industrials 14.02%
3 Technology 13.29%
4 Consumer Staples 10.45%
5 Financials 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
226
UnitedHealth
UNH
$371B
$254K 0.03%
1,550
– –
BWA icon
227
BorgWarner
BWA
$13.8B
$247K 0.03%
6,702
-171
-2% -$6.23K
COST icon
228
Costco
COST
$423B
$234K 0.03%
1,393
– –
SAIC icon
229
Saic
SAIC
$5.18B
$222K 0.03%
2,985
– –
ENB icon
230
Enbridge
ENB
$114B
$221K 0.03%
+5,066
New +$214K
BEN icon
231
Franklin Resources
BEN
$17.7B
$209K 0.03%
+4,965
New +$206K
HRB icon
232
H&R Block
HRB
$5.68B
$209K 0.03%
9,000
– –
IEUS icon
233
iShares MSCI Europe Small-Cap ETF
IEUS
$183M
$209K 0.03%
+4,400
New +$202K
NXPI icon
234
NXP Semiconductors
NXPI
$58.5B
$207K 0.03%
+2,000
New +$202K
XLE icon
235
State Street Energy Select Sector SPDR ETF
XLE
$37.9B
$203K 0.03%
5,800
– –
CHTR icon
236
Charter Communications
CHTR
$18.2B
$202K 0.02%
+618
New +$197K
AVP
237
DELISTED
Avon Products, Inc.
AVP
$133K 0.02%
30,295
– –
NMM icon
238
Navios Maritime Partners
NMM
$2.25B
$49K 0.01%
1,570
– –
ATXS
239
DELISTED
Astria Therapeutics
ATXS
$39K ﹤0.01%
+408
New +$56.2K
ETN icon
240
Eaton
ETN
$174B
– –
-3,240
Closed -$217K
PPG icon
241
PPG Industries
PPG
$26.3B
– –
-2,382
Closed -$226K
TEVA icon
242
Teva Pharmaceuticals
TEVA
$40.1B
– –
-72,929
Closed -$2.64M
TTE icon
243
TotalEnergies
TTE
$191B
– –
-41,546,300
Closed -$262K
ZEUS
244
DELISTED
Olympic Steel
ZEUS
– –
-9,900
Closed -$240K
SYNT
245
DELISTED
Syntel Inc
SYNT
– –
-37,131
Closed -$735K
SE
246
DELISTED
Spectra Energy Corp Wi
SE
– –
-5,150
Closed -$212K
6 7 8 9
10

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
JFGLC
Johnson Financial Group LLC (Colorado) Denver, Colorado $1.5B AUM 16.09% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return
SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return

Boston Family Office's Q1 2017 Portfolio in Review

As of Q1 2017, Boston Family Office held 251 positions worth $813M, up 5.6% from $770M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Family Office's Q1 2017 filing shows 10 new, 63 increased, 107 reduced and 7 closed positions. Its largest new stake was Teradyne: 22,100 shares worth $687K. The largest sale was Teva Pharmaceuticals, an estimated $2.64M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

  • Boston Family Office's largest Q1 2017 buy was Teradyne: 22,100 shares worth $687K.
  • Boston Family Office added most to Automatic Data Processing in Q1 2017, an estimated $2.9M increase.
  • Boston Family Office's biggest Q1 2017 reduction was Middleby, cutting an estimated $2.44M.
  • Boston Family Office fully exited Teva Pharmaceuticals in Q1 2017, selling an estimated $2.64M.
  • Boston Family Office's ten largest holdings make up 21% of its $813M portfolio in Q1 2017.
  • Boston Family Office opened 10 new positions and closed 7 in Q1 2017.
  • Boston Family Office's portfolio value rose 5.6% quarter-over-quarter to $813M.

Based on Boston Family Office's 13F filing for Q1 2017, filed 5 May 2017.